Mangoceuticals, Inc. - Common Stock

Share · US56270V1061 · MGRX (XNAS)

No Price

29.01.2026 00:20

Current Prices from Mangoceuticals, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	MGRX	USD	29.01.2026 00:20	0,46 USD	0,02 USD +4,54 %

Share Float & Liquidity

Free Float 48,56 %

Shares Float 5,55 M

Shares Outstanding 11,44 M

Company Profile for Mangoceuticals, Inc. - Common Stock Share

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

AI Analysis of Mangoceuticals, Inc. - Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Mangoceuticals, Inc. - Common Stock

No AI threads available for this company yet.

Company Data

Name Mangoceuticals, Inc. - Common Stock

Company Mangoceuticals, Inc.

Symbol MGRX

Website https://www.mangorx.com

Primary Exchange

NASDAQ

ISIN US56270V1061

Asset Class Share

Sector Healthcare

Industry Medical - Healthcare Information Services

CEO Jacob D. Cohen

Market Capitalization 13 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 15110 North Dallas Parkway, 75248 Dallas

IPO Date 2023-03-21

Stock Splits

Date	Split
16.10.2024	1:15

Ticker Symbols

Name	Symbol
NASDAQ	MGRX

More Shares

Investors who hold Mangoceuticals, Inc. - Common Stock also have the following shares in their portfolio:

DZ BANK IS.7144VAR Bond

ZEBRA TECHNOLOGIESLOGIES CORP - CLASS A Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog